Tower Research Capital LLC (Trc) Arbutus Biopharma Corp Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,859 shares of ABUS stock, worth $5,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,859

Previous 6,255 70.28%

Holding current value

$5,874

Previous $15,000 73.33%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.26 - $2.92 $9,934 - $12,836	-4,396 Reduced 70.28%	1,859 $4,000
Q4 2023 Feb 13, 2024	SELL	$1.69 - $2.54 $5,499 - $8,265	-3,254 Reduced 34.22%	6,255 $15,000
Q3 2023 Nov 14, 2023	BUY	$1.9 - $2.27 $4,554 - $5,441	2,397 Added 33.7%	9,509 $19,000
Q2 2023 Aug 14, 2023	SELL	$2.24 - $3.06 $6,003 - $8,200	-2,680 Reduced 27.37%	7,112 $16,000
Q1 2023 May 09, 2023	SELL	$2.23 - $3.1 $11,207 - $15,580	-5,026 Reduced 33.92%	9,792 $30,000

Q4 2022 Feb 10, 2023	BUY	$1.91 - $2.85 $7,964 - $11,884	4,170 Added 39.16%	14,818 $35,000
Q3 2022 Nov 10, 2022	SELL	$1.88 - $2.88 $10,105 - $15,480	-5,375 Reduced 33.55%	10,648 $21,000
Q2 2022 Aug 15, 2022	BUY	$1.98 - $3.17 $10,791 - $17,276	5,450 Added 51.55%	16,023 $43,000
Q1 2022 May 12, 2022	BUY	$2.42 - $3.98 $14,430 - $23,732	5,963 Added 129.35%	10,573 $31,000
Q4 2021 Feb 14, 2022	SELL	$3.11 - $4.61 $3,582 - $5,310	-1,152 Reduced 19.99%	4,610 $17,000
Q3 2021 Nov 15, 2021	SELL	$2.65 - $4.62 $7,536 - $13,139	-2,844 Reduced 33.05%	5,762 $25,000
Q2 2021 Aug 16, 2021	BUY	$2.5 - $3.51 $10,395 - $14,594	4,158 Added 93.48%	8,606 $26,000
Q1 2021 May 17, 2021	SELL	$3.14 - $4.84 $408 - $629	-130 Reduced 2.84%	4,448 $15,000
Q4 2020 Feb 16, 2021	BUY	$2.76 - $4.97 $482 - $869	175 Added 3.97%	4,578 $16,000
Q3 2020 Nov 16, 2020	SELL	$1.75 - $6.2 $12,146 - $43,034	-6,941 Reduced 61.19%	4,403 $14,000
Q2 2020 Aug 13, 2020	SELL	$0.91 - $2.36 $818 - $2,121	-899 Reduced 7.34%	11,344 $21,000
Q1 2020 May 15, 2020	BUY	$1.01 - $3.42 $12,264 - $41,529	12,143 Added 12143.0%	12,243 $12,000
Q4 2019 Feb 07, 2020	SELL	$0.87 - $2.89 $33,659 - $111,811	-38,689 Reduced 99.74%	100 $0
Q3 2019 Nov 05, 2019	BUY	$1.34 - $2.4 $45,566 - $81,612	34,005 Added 710.81%	38,789 $59,000
Q2 2019 Aug 13, 2019	SELL	$1.46 - $4.44 $4,177 - $12,702	-2,861 Reduced 37.42%	4,784 $10,000
Q1 2019 May 14, 2019	SELL	$3.41 - $4.57 $8,743 - $11,717	-2,564 Reduced 25.12%	7,645 $28,000
Q4 2018 Feb 14, 2019	BUY	$3.5 - $9.66 $30,264 - $83,530	8,647 Added 553.59%	10,209 $39,000
Q3 2018 Nov 13, 2018	BUY	$7.85 - $12.35 $6,672 - $10,497	850 Added 119.38%	1,562 $15,000
Q2 2018 Aug 15, 2018	SELL	$5.0 - $7.35 $9,180 - $13,494	-1,836 Reduced 72.06%	712 $5,000
Q1 2018 May 15, 2018	BUY	$4.4 - $6.05 $11,211 - $15,415	2,548 New	2,548 $13,000
Q4 2017 Feb 09, 2018	SELL	$4.45 - $7.7 $36,859 - $63,779	-8,283 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.4 - $7.0 $28,162 - $57,981	8,283	8,283 $51,000

Others Institutions Holding ABUS

# of Institutions

130

Shares Held

82.2M

Call Options Held

4.82M

Put Options Held

546K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $474M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Arbutus Biopharma Corp Transaction History